Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.35    0.08 (1.87%)
Bid:
4.31
Ask:
4.44
Spread: 0.13 (3.016%)
Market Cap: £208.78m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Year end trading update

3 Aug 2018 07:00

RNS Number : 7090W
Seeing Machines Limited
03 August 2018
 

3 August 2018

Seeing Machines Limited

 

Year end trading update

 

Seeing Machines Limited (AIM: SEE, "Seeing Machines", the "Group"), the advanced computer vision technology company that designs AI powered operator monitoring systems to improve transport safety, has published a trading update for the financial year to 30 June 2018.

 

Total sales revenue was A$30.7 million, an increase of 127% year-on-year (2017: A$13.5 million) and within the range of the previous guidance published on 21 May 2018. Revenue momentum accelerated through the year with sales in H2 being more than 9% higher than in H1.

 

Gross profit increased year-on-year (2017: A$nil), principally attributable to a greater proportion of the revenue coming from the high-margin Automotive, Off-Road and Rail markets. Fleet margin also improved year-on-year due to the high-margin fleet monitoring Monthly Recurring Revenue ("MRR") from its growing connected customer base.

 

Overall gross margin was impacted by the previously-announced delays to shipments of, and higher-than-expected final hardware costs associated with, Fleet Guardian Gen 2. Gross margin is expected to be below the Board's expectations for FY2018, with a consequent impact on gross profit for the year.

 

Cash and cash equivalents at 30 June 2018 totalled A$43.4 million (£24.6 million).

 

In January 2018, Seeing Machines completed a £35 million (gross) fundraise, alongside a £2.4 million offer to existing shareholders to accelerate its investment in its AI platform and product development, as well as to scale its infrastructure and global footprint in order to meet sustained customer demand for its leading-edge Driver Monitoring Systems ("DMS") solutions.

 

Notable highlights during the period include:

 

· Production awards secured with two premium German automotive OEMs and a global US-headquartered automotive OEM.

· A further production award with a Chinese OEM confirmed in July 2018, taking the number of awarded programmes to five, with numerous new vehicle models launching in the 2019-2022 timeframe.

· Projected automotive revenue from this booked business to be recognised from 2019 to 2026 is in the range of A$110 million based on initial models included in the corresponding agreements. The addition of further models is currently in discussion.

· Recent design awards saw the launch of the Group's proprietary FOVIO Chip. The Group's ability to deliver its DMS technology on the FOVIO Chip broadens its addressable market considerably, particularly given the timeframes in which OEMs are beginning to implement semi-automated driving technology and incorporating DMS to enhance safety and meet pending regulatory guidance globally.

The FOVIO Chip will also be leveraged across the business to provide the Seeing Machines DMS platform across multiple transport sectors.

· The Automotive business now has established offices in two additional important markets, Germany and Japan, where its local people are supporting the growing DMS requirements of existing and potential automotive Tier 1 customers.

· The Fleet business had over 10,000 units connected with more than 300 customers worldwide as at 30 June 2018. As the business transitions to channel sales, working closely with its distribution partners, a small number of flagship multi-national accounts will be managed directly. These accounts are mostly focused on passenger transportation, which is higher value and includes major international brands such as Coach USA and First.

· Guardian Gen 2 successfully launched and, despite initial manufacturing delays, over 5,500 units now shipped to distribution partners.

· Jack Boyer OBE was appointed non-executive director and Chairman designate in July, and, at the same time, Ken Kroeger was returned as CEO on a permanent basis.

 

The Group expects to publish its audited year end results in late September 2018.

 

The financial results in this announcement are based on the unaudited management accounts for the year to 30 June 2018.

 

Ken Kroeger, CEO, commented:

 

"The key driver for our rapid revenue growth last year was our Fleet business, with sales more than 89% up in that division. As we develop our channel strategy and further refine the business model, we look forward to continued growth.

 

"Automotive sales was the other major contributor with a 5x increase in sales on the prior year. As we are now working with an increasing number of automotive Tier 1 customers globally and are actively engaged on programs with five OEMs in North America, Europe and China, we are considered a world-leader in DMS for automotive applications.

 

"We are also continuing to develop the significant opportunities with global market leaders in the Aviation and Rail segments. Following the signing of the extended partnership agreement with Progress Rail in 2017, we received its maiden revenue for this business unit in FY18."

 

Enquiries:

 

Seeing Machines Limited www.seeingmachines.com

+61 2 6103 4700

Ken Kroeger, Executive Chairman & CEO

Sophie Nicoll, VP Marketing & Communications

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Neil McDonald/Beth McKiernan/Pete Lynch

+44 131 220 6939

 

 

Canaccord Genuity Limited (Joint Broker)

+44 20 7523 8000

Simon Bridges/Richard Andrews/Alexander Napier

 

 

 

Instinctif Partners

+44 20 7457 2077

Kay Larsen/Chantal Woolcock/Adrian Duffield

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

About Seeing Machines

 

Seeing Machines (LSE: SEE), a global company headquartered in Australia, is an industry leader in computer vision technologies which enable machines to see, understand and assist people. The Company's machine learning vision platform has the know-how to deliver real-time understanding of drivers through Artificial Intelligence (AI) analysis of heads, faces and eyes. This insight enables Driver Monitoring Systems (DMS), which monitor driver/operator attention and can identify drowsiness and distraction across multiple transport sectors.

 

Seeing Machines develops DMS for the Automotive, Commercial Fleet, Aviation, Rail and Off-Road markets. The Company has offices in Australia, USA, Europe and Asia, and delivers multi-platform solutions ranging from embedded software and processors to aftermarket system and service solutions to industry leaders in each vertical.

 

DMS is now considered a core safety technology for the Automotive industry, particularly with the development of semi-autonomous and self-driving cars. DMS is also increasingly seen to be an integral safety feature across the Commercial Transport & Logistics industry globally. www.seeingmachines.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFKBDKBBKBCFK
Date   Source Headline
7th Aug 20097:00 amRNSAppointment of broker
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.